🇺🇸 FDA
Drug

lenalidomide

Brand: LENALIDOMIDE

approved

Quick answer

lenalidomide (LENALIDOMIDE), is a pharmaceutical active ingredient, associated with Amneal Pharmaceuticals, with approved status in the US.

Key facts

INN
lenalidomide
Brand
LENALIDOMIDE
Route
ORAL
Formulation
CAPSULE
Originator
Amneal Pharmaceuticals

Related patents

patent

US 11253591

Combination of lenalidomide and polypeptide construct, and uses thereof

Expires Mon Feb 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 10342869

Compositions comprising anti-CD38 antibodies and lenalidomide

Expires Mon Jul 04 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 10232041

Combination of lenalidomide and polypeptide construct, and uses thereof

Expires Mon Mar 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 9636334

Combination of lenalidomide and polypeptide construct, and uses thereof

Expires Mon Apr 27 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

Frequently asked questions

What is lenalidomide?

lenalidomide (LENALIDOMIDE), is a pharmaceutical active ingredient, associated with Amneal Pharmaceuticals, with approved status in the US.

What is the brand name for lenalidomide?

LENALIDOMIDE is a marketed brand name for lenalidomide. Check FDA Drugs@FDA for the current US label holder.